Investasi
Fitur
BiayaKeamanan
Akademi
Lainnya
Pluang+

Bandingkan Harga & Kinerja Alakasa Industrindo Tbk (ALKA) vs Dharma Polimetal Tbk. (DRMA)

Alakasa Industrindo TbkTrading
Dharma Polimetal Tbk.Trading

Kinerja harga (24 Jam Terakhir)

Statistik utama

Perbedaan Alakasa Industrindo Tbk dan Dharma Polimetal Tbk.: Alakasa Industrindo Tbk diperdagangkan di Rp2.570 (kapitalisasi pasar 1,3 T), sedangkan Dharma Polimetal Tbk. diperdagangkan di Rp985 (kapitalisasi pasar 4,64 T, volume 24 jam 57,6 rb). Perbedaan utamanya: Dharma Polimetal Tbk. jauh lebih besar — sekitar 3,6× kapitalisasi pasar Alakasa Industrindo Tbk. Mana yang lebih baik tergantung tujuan investasimu.

ALKADRMA
Kapitalisasi Pasar
1,3 T4,64 T
Harga Ekuilibrium Indikatif
2.820985
Volume Ekuilibrium Indikatif
43454,6 rb
Volume
57,6 rb
Lot
576
Perputaran
56,74 jt
Harga Rata-rata
985
Nilai Transaksi
56,74 jt

Perbandingan imbal hasil

Imbal hasil berjalan pada periode standar

Berita terkini

Berita terbaru kedua aset

ALKA
Lihat detail
DRMA
Lihat detail

Tentang Alakasa Industrindo Tbk

PT. Alakasa Industrindo Tbk was established on February 21, 1972 within the framework of the foreign capital Investment law N0. 1 1967, under the name of PT Alcan Indonesia, as a join venture enterprise (PMA company) between Alcan Aluminium Holding Ld (Alcan) and the Municipal Government of Jakarta. In August 1988, Alcan sold all of its shares to the Municipal Government of Jakarta (DKI) and the company status was consequently changed to a Domestic Capital Investment Company (PMDN Company). The Company’s name was then changed to PT Alumindo Perkasa.

Selengkapnya di halaman ALKA

Tentang Dharma Polimetal Tbk.

PT Dharma Polimetal Tbk (“the Company”) was established in the Republic of Indonesia on 27 March based on Notarial deed No. 74 of Rukmasanti Hardjasatya, S.H. The Company begin opertions on year 1989 and commenced its commercial activities since 1990. The Company’s Majority shareholder is PT Dharma Inti Anugerah, established in Republic Indonesia on 20 November 2003.

Selengkapnya di halaman DRMA